Skip to main content
. 2017 Aug 1;43(3):289–296. doi: 10.5152/tud.2017.35467

Table 3.

Comparison of testosterone levels according to the risk groups

Total testosterone (ng/dL) p Free testosterone (ng/dL) p Bioavailable testosterone (ng/dL) p
High risk cancer 347±128 0.443 6.1±2 0.001 148±48 0.0001
Benign, low and intermediate risk 328±124 5.2±1.6 124±43